CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 76 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q2 2019. The put-call ratio across all filers is 1.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $686,000 | +4.4% | 7,200 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $657,000 | +20.3% | 7,200 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $546,000 | -5.2% | 7,200 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $576,000 | -19.4% | 7,200 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $715,000 | +22.6% | 7,200 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $583,000 | +2.8% | 7,200 | 0.0% | 0.00% | +50.0% |
| Q4 2017 | $567,000 | -14.6% | 7,200 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $664,000 | – | 7,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEW SILK ROAD INVESTMENT PTE LTD | 189,395 | $17,476,000 | 9.13% |
| VERNIER CAPITAL PARTNERS, LP | 122,600 | $11,312,000 | 8.31% |
| RUDMAN ERROL M | 26,901 | $2,482,000 | 1.42% |
| HERMES INVESTMENT MANAGEMENT LTD | 712,424 | $65,735,000 | 0.99% |
| Hillhouse Capital Management | 618,391 | $57,059,000 | 0.94% |
| COMGEST GLOBAL INVESTORS S.A.S. | 356,252 | $32,872,000 | 0.76% |
| CORNERSTONE CAPITAL MANAGEMENT HOLDINGS LLC. | 363,190 | $33,511,000 | 0.26% |
| FIL Ltd | 914,848 | $84,413,000 | 0.24% |
| Gideon Capital Advisors, Inc. | 2,494 | $230,000 | 0.23% |
| WASATCH ADVISORS LP | 137,482 | $12,685,000 | 0.17% |